Luo F - Search Results

1

Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma.

Lei D, Hu G, Chen Y, Hao T, Gao Y, Luo F. Lei D, et al. Among authors: luo f. Onco Targets Ther. 2020 Nov 17;13:11839-11848. doi: 10.2147/OTT.S272596. eCollection 2020. Onco Targets Ther. 2020. PMID: 33235470 Free PMC article.

2

[Knockdown of B7-H4/VTCN1 promotes apoptosis and autophagy of Huh7 cells by inhibiting phosphorylation of JNK].

Hao T, Lei D, Hu G, Liao R, Luo F. Hao T, et al. Among authors: luo f. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Jul;36(7):603-608. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020. PMID: 32727644 Chinese.

3

Inhibition of B7-H4 promotes hepatocellular carcinoma cell apoptosis and autophagy through the PI3K signaling pathway.

Hao TT, Liao R, Lei DL, Hu GL, Luo F. Hao TT, et al. Among authors: luo f. Int Immunopharmacol. 2020 Nov;88:106889. doi: 10.1016/j.intimp.2020.106889. Epub 2020 Aug 14. Int Immunopharmacol. 2020. PMID: 32805693

4

An angiogenesis-related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma.

Lei D, Chen Y, Zhou Y, Hu G, Luo F. Lei D, et al. Among authors: luo f. Biosci Rep. 2021 Apr 30;41(4):BSR20204442. doi: 10.1042/BSR20204442. Biosci Rep. 2021. PMID: 33764367 Free PMC article.

5

A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma.

Lei D, Chen Y, Zhou Y, Hu G, Luo F. Lei D, et al. Among authors: luo f. Front Oncol. 2021 Nov 26;11:716757. doi: 10.3389/fonc.2021.716757. eCollection 2021. Front Oncol. 2021. PMID: 34900672 Free PMC article.

6

A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma.

Zhou Y, Lei D, Hu G, Luo F. Zhou Y, et al. Among authors: luo f. Front Oncol. 2022 Mar 28;12:760190. doi: 10.3389/fonc.2022.760190. eCollection 2022. Front Oncol. 2022. PMID: 35419294 Free PMC article.

7

Conduction and validation of a novel mitotic spindle assembly related signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.

Zhang Z, Zhang Y, Hu G, Wu Q, Zhou Y, Luo F. Zhang Z, et al. Among authors: luo f. Front Genet. 2024 Jul 19;15:1412303. doi: 10.3389/fgene.2024.1412303. eCollection 2024. Front Genet. 2024. PMID: 39100078 Free PMC article.

8

[Association between RsaI and AluI polymorphism in the estrogen receptor beta gene and primary hepatocellular carcinoma.].

Zhang W, Shi D, DU CY, Luo F. Zhang W, et al. Among authors: luo f. Zhonghua Gan Zang Bing Za Zhi. 2009 Feb;17(2):99-101. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19254455 Chinese.

9

GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor‑associated macrophages.

Zhu F, Li X, Jiang Y, Zhu H, Zhang H, Zhang C, Zhao Y, Luo F. Zhu F, et al. Among authors: luo f. Oncol Rep. 2015 Nov;34(5):2643-55. doi: 10.3892/or.2015.4268. Epub 2015 Sep 9. Oncol Rep. 2015. PMID: 26352004

10

Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma.

Zhu F, Li X, Chen S, Zeng Q, Zhao Y, Luo F. Zhu F, et al. Among authors: luo f. Med Oncol. 2016 Feb;33(2):17. doi: 10.1007/s12032-016-0729-9. Epub 2016 Jan 19. Med Oncol. 2016. PMID: 26781124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,559 results

Search Page

Filters